Inventor · disambiguated record
Naoki Okumura
Also filed as: OKUMURA NAOKI
21 granted patents·15 pending applications·6 citations·filing 1976–2025
89Inventor score
Files withKYOTO PREFECTURAL PUBLIC UNIV CORP16THE DOSHISHA15JAPAN CHEM RES2NIPPON STEEL CORP1TABATA YASUHIKO1
Top patents by PatentIndex Score
36 records- 0182US11433090B2mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereofTHE DOSHISHA·Filed 2018·Granted Sep 6, 2022·1 cites·16 claims
- 0280US2024402171A1Corneal endothelial cell markerKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2024·Application pending·0 cites
- 0378US12343356B2mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereofTHE DOSHISHA·Filed 2022·Granted Jul 1, 2025·0 cites·13 claims
- 0478US11382904B2Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endotheliumKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2014·Granted Jul 12, 2022·1 cites·19 claims
- 0578US2025302883A1Normalization of culture of corneal endothelial cellsKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2025·Application pending·0 cites
- 0677US2023057984A1Normalization of culture of corneal endothelial cellsKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2022·Application pending·0 cites
- 0772US8895508B2Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particlesTABATA YASUHIKO·Filed 2009·Granted Nov 25, 2014·1 cites·6 claims
- 0872US2023310402A1Corneal endothelium ecm therapeutic medicamentsKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2023·Application pending·0 cites
- 0968US12072334B2Corneal endothelial cell markerKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2020·Granted Aug 27, 2024·0 cites·15 claims
- 1068US2022296580A1Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endotheliumKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2022·Application pending·0 cites
- 1166US2025230406A1Corneal endothelial cell preparation containing no culture-derived component, and method for producing sameTHE DOSHISHA·Filed 2023·Application pending·0 cites
- 1265US11445723B2Method and container for preserving corneal endothelial cellsTHE DOSHISHA·Filed 2019·Granted Sep 20, 2022·0 cites·15 claims
- 1365US2025000083A1Cryopreservation preparation for corneal endothelial cells and method for producing said cryopreservation preparationTHE DOSHISHA·Filed 2022·Application pending·0 cites
- 1464US11730722B2Corneal endothelium ECM therapeutic medicamentsKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2013·Granted Aug 22, 2023·0 cites·9 claims
- 1564US10813920B2Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damageTHE DOSHISHA·Filed 2014·Granted Oct 27, 2020·0 cites·3 claims
- 1664US9616101B2Differentiation marker and differentiation control of eye cellKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2013·Granted Apr 11, 2017·0 cites·13 claims
- 1764US2021121494A1Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereofTHE DOSHISHA·Filed 2020·Application pending·0 cites
- 1861US11857544B2Composition or method including (t)ew-7197 for treating or preventing corneal endothelial diseasesTHE DOSHISHA·Filed 2018·Granted Jan 2, 2024·0 cites·10 claims
- 1961US10959997B2Combined agent for cell therapy of corneal endothelial cellKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2013·Granted Mar 30, 2021·0 cites·8 claims
- 2060US10908161B2Corneal endothelial cell markerKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2014·Granted Feb 2, 2021·0 cites·10 claims
- 2155US11446263B2Caspase inhibitor-containing drug for treating or preventing disorders caused by TGF-β, and applications thereofTHE DOSHISHA·Filed 2016·Granted Sep 20, 2022·0 cites·20 claims
- 2255US2021207088A1Composition and method for preserving or culturing ocular cellsTHE DOSHISHA·Filed 2019·Application pending·0 cites
- 2354US11624053B2Application of laminin to corneal endothelial cell cultureKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2014·Granted Apr 11, 2023·0 cites·3 claims
- 2454US2017202910A1Differentiation marker and differentiation control of eye cellKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2017·Application pending·0 cites
- 2553US2015044178A1Normalization of culture of corneal endothelial cellsKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2012·Application pending·0 cites
- 2652US2021059995A1Composition for Protecting CorneaUNIV KYOTO·Filed 2018·Application pending·0 cites
- 2751US11633477B2Treatment of cornea using lamininKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2015·Granted Apr 25, 2023·0 cites·15 claims
- 2851US2021259960A1Formulation containing emricasanTHE DOSHISHA·Filed 2019·Application pending·0 cites
- 2947US2020121652A1Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agentTHE DOSHISHA·Filed 2018·Application pending·0 cites
- 3046US11918630B2Treatment of retina and nerve using lamininKYOTO PREFECTURAL PUBLIC UNIV CORP·Filed 2015·Granted Mar 5, 2024·0 cites·3 claims
- 3146US10980787B2Drug for treating or preventing disorder caused by TGF-B signals, and application thereofTHE DOSHISHA·Filed 2016·Granted Apr 20, 2021·0 cites·4 claims
- 3244US10335439B2Method for producing human corneal epithelium sheetJAPAN CHEM RES·Filed 2014·Granted Jul 2, 2019·0 cites·16 claims
- 3344US2020386744A1Novel screening method for tgf-beta inhibitorTHE DOSHISHA·Filed 2018·Application pending·0 cites
- 3443US11576914B2Drug for treating or preventing disorder caused by TGF-β signaling, and application thereofTHE DOSHISHA·Filed 2018·Granted Feb 14, 2023·0 cites·9 claims
- 3543US10174284B2Medium, for culturing corneal endothelial cells, containing conditioned medium from mesenchymal stem cellsJAPAN CHEM RES·Filed 2013·Granted Jan 8, 2019·0 cites·14 claims
- 3635US4119442AProcess for manufacturing a steel productNIPPON STEEL CORP·Filed 1976·Granted Oct 10, 1978·3 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Naoki Okumura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →